CollPlant Biotechnologies Ltd.
NASDAQ: CLGN
Healthcare
Biotechnology
Global Rank
#44810
Country Rank
#552
Market Cap
6.24 M
Price
3.3
Change (%)
3.28%
Volume
20,612
CollPlant Biotechnologies Ltd.'s latest marketcap:
6.24 M
As of 09/04/2026, CollPlant Biotechnologies Ltd.'s market capitalization has reached $6.24 M. According to our data, CollPlant Biotechnologies Ltd. is the 44810th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.24 M |
| Revenue (ttm) | 389,000 |
| Net Income (ttm) | -13,134,000 |
| Shares Out | 1.89 M |
| EPS (ttm) | -10.28 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/15/2026 |
Market Cap Chart
Data Updated: 09/04/2026
CollPlant Biotechnologies Ltd.'s yearly market capitalization.
CollPlant Biotechnologies Ltd. has seen its market value drop from $42.21 M to $6.24 M since 2015, representing a total decrease of 85.22% and an annual compound decline rate (CAGR) of 16.27%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 09/04/2026 | $6.24 M | -69.83% | 44810 |
| 12/31/2025 | $17.9 M | -56.55% | 35887 |
| 12/31/2024 | $41.2 M | -43.72% | 29321 |
| 12/29/2023 | $73.2 M | -20.95% | 25202 |
| 12/30/2022 | $92.6 M | -47.06% | 22737 |
| 12/31/2021 | $174.9 M | 147.03% | 19630 |
| 12/31/2020 | $70.8 M | 226.27% | 22664 |
| 12/31/2019 | $21.7 M | 55% | n/a |
| 12/31/2018 | $14 M | -45.68% | n/a |
| 12/22/2017 | $25.77 M | 111.04% | n/a |
Company Profile
CollPlant Biotechnologies Ltd. was founded in 2004 in Israel.
on the Nasdaq Stock Market.
With 39 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is CollPlant Biotechnologies Ltd.'s (CLGN) current market cap?As of 09/04/2026, CollPlant Biotechnologies Ltd. (including the parent company, if applicable) has an estimated market capitalization of $6.24 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CollPlant Biotechnologies Ltd. (CLGN) rank globally by market cap?CollPlant Biotechnologies Ltd. global market capitalization ranking is approximately 44810 as of 09/04/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.